SLGN:NYSESilgan Holdings Inc. Analysis
Data as of 2026-09-01 - not real-time
$41.54
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Silgan Holdings Inc. trades at $41.54, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has lost 9.8% over the past 30 days. Momentum indicators put RSI at 44.9 (neutral) with MACD reading bullish. Watch $40.23 as support and $43.56 as the nearer resistance level.
Multiples put this in undervalued territory at a P/E of 16.5. Sell-side targets cluster 33.1% above the current quote. Revenue is growing at 6.8% on a 4.0% profit margin. The 2.00% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 45.6%, a beta of 0.54 and a maximum drawdown of 25.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.
Multiples put this in undervalued territory at a P/E of 16.5. Sell-side targets cluster 33.1% above the current quote. Revenue is growing at 6.8% on a 4.0% profit margin. The 2.00% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 45.6%, a beta of 0.54 and a maximum drawdown of 25.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.
Top Market Events
Silgan SLGN delivered earnings and revenue surprises of +2.Rigid packaging solutions manufacturer Silgan Holdings NYSE:SLGN reported Q2 CY2026 results , with sales up 6.Silgan SLGN doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 41.84
- MACD momentum is positive
- 30-day price change of -9.8%
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 41.84
- Analyst targets imply +33.1% versus the current price
- 30-day volatility of 45.6%
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Analyst targets imply +33.1% versus the current price
- P/E ratio of 16.5
- Elevated debt-to-equity of 203
Key Metrics & Analysis
Financial Health
Revenue Growth6.80%
Profit Margin4.04%
P/E Ratio16.5
ROE11.75%
ROA4.24%
Debt/Equity203.15
P/B Ratio1.8
Op. Cash Flow$640.8M
Free Cash Flow$313.3M
Technical Analysis
TrendNeutral
RSI44.9
Support$40.23
Resistance$43.56
MA 20$41.85
MA 50$43.70
MA 200$41.84
MACDBullish
VolumeStable
Fear & Greed Index94.79
Valuation
Fair Value$7.98
Target Price$55.31
Upside/Downside33.14%
GradeUndervalued
TypeBlend
Dividend Yield2.00%
Risk Assessment
Beta0.54
Volatility45.59%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWTS
Watts Water Technologies, Inc.
STOCKAMZN
Amazon.com, Inc.
STOCKBLK
BlackRock, Inc.
STOCKUSFD
US Foods Holding Corp.
STOCKUSAC
USA Compression Partners, LP
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.